Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Performance Score | Market Cap | Revenue | EBITDA | Earnings | EPS | Revenue Growth Y/Y | Revenue Growth 5Y | Earnings Growth Y/Y | Earnings Growth 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ATNM | ACTINIUM PHARMACEUTICALS INC | $291.88M | $81.00k | -$45.63M | -$46.45M | -$1.71 | -10.00% | N/A | N/A | N/A | ||
| CRGX | CARGO THERAPEUTICS INC | $804.06M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| PYXS | PYXIS ONCOLOGY INC | $244.39M | $16.15M | -$54.27M | -$57.80M | -$1.36 | N/A | N/A | N/A | N/A | 2024-06-11 | |
| CWH | CAMPING WORLD HOLDINGS INC | $1.73B | $6.10B | $358.79M | $5.57M | $0.14 | -10.13% | 4.93% | -93.89% | N/A | ||
| CTNM | CONTINEUM THERAPEUTICS INC | $398.71M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| IREN | IRIS ENERGY LTD | $833.24M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| EYPT | EYEPOINT PHARMACEUTICALS INC | $616.68M | $50.02M | -$77.74M | -$78.92M | -$1.81 | 25.70% | 54.65% | N/A | N/A | ||
| ANNX | ANNEXON INC | $400.15M | $0.00 | -$117.42M | -$120.74M | -$1.46 | N/A | N/A | N/A | N/A | 2024-06-05 | |
| ALXO | ALX ONCOLOGY HOLDINGS INC | $740.34M | $0.00 | -$163.76M | -$166.20M | -$3.71 | N/A | N/A | N/A | N/A | 2024-06-12 | |
| ACHR | ARCHER AVIATION INC | $1.20B | $0.00 | -$466.10M | -$461.30M | -$1.62 | N/A | N/A | N/A | N/A | ||
| VKTX | VIKING THERAPEUTICS INC | $7.39B | $0.00 | -$93.43M | -$93.72M | -$0.93 | N/A | N/A | N/A | N/A | 2024-05-21 | |
| PBPB | POTBELLY CORP | $260.52M | $484.29M | $45.57M | $3.68M | $0.14 | 2.60% | 3.00% | -62.16% | N/A | ||
| RZLT | REZOLUTE INC | $105.96M | $0.00 | -$57.66M | -$58.21M | -$1.14 | N/A | N/A | N/A | N/A | ||
| STRO | SUTRO BIOPHARMA INC | $328.00M | $154.07M | -$75.58M | -$114.96M | -$1.88 | 106.66% | 30.15% | N/A | N/A | 2024-06-06 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.